DE69517356T2 - Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität - Google Patents

Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität

Info

Publication number
DE69517356T2
DE69517356T2 DE69517356T DE69517356T DE69517356T2 DE 69517356 T2 DE69517356 T2 DE 69517356T2 DE 69517356 T DE69517356 T DE 69517356T DE 69517356 T DE69517356 T DE 69517356T DE 69517356 T2 DE69517356 T2 DE 69517356T2
Authority
DE
Germany
Prior art keywords
fertility
disubstituted
medicament
substituted
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69517356T
Other languages
English (en)
Other versions
DE69517356D1 (de
Inventor
Armelle Bonfils
Daniel Philibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Application granted granted Critical
Publication of DE69517356D1 publication Critical patent/DE69517356D1/de
Publication of DE69517356T2 publication Critical patent/DE69517356T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69517356T 1994-03-24 1995-03-22 Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität Expired - Fee Related DE69517356T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403460A FR2717690B1 (fr) 1994-03-24 1994-03-24 Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.

Publications (2)

Publication Number Publication Date
DE69517356D1 DE69517356D1 (de) 2000-07-13
DE69517356T2 true DE69517356T2 (de) 2000-12-14

Family

ID=9461385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69517356T Expired - Fee Related DE69517356T2 (de) 1994-03-24 1995-03-22 Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität

Country Status (16)

Country Link
US (5) US5554604A (de)
EP (1) EP0676202B1 (de)
JP (1) JP3678454B2 (de)
KR (1) KR100367805B1 (de)
CN (1) CN1055391C (de)
AT (1) ATE193650T1 (de)
AU (1) AU698349B2 (de)
CA (1) CA2145469A1 (de)
DE (1) DE69517356T2 (de)
DK (1) DK0676202T3 (de)
ES (1) ES2147267T3 (de)
FR (1) FR2717690B1 (de)
GR (1) GR3033882T3 (de)
HU (1) HUT72085A (de)
PT (1) PT676202E (de)
RU (1) RU2176506C2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742337B1 (fr) * 1995-12-13 1998-03-06 Roussel Uclaf Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments
US5834225A (en) * 1997-01-15 1998-11-10 Board Of Trustees Operating Michigan State University Method, device and test kit for capacitation of sperm
DE19917930A1 (de) * 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
JP2004518637A (ja) * 2000-11-03 2004-06-24 ワシントン・ユニバーシティ 細胞保護活性を有する修飾されたヒドロキシ置換芳香族構造体
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
JP4045090B2 (ja) * 2001-11-06 2008-02-13 オムロン株式会社 静電アクチュエータの調整方法
US7687486B2 (en) * 2003-04-29 2010-03-30 Florida Agricultural & Mechanical University Selective estrogen receptor modulators
US10397672B2 (en) 2016-06-20 2019-08-27 Cable Television Laboratories, Inc. Systems and methods for intelligent edge to edge optical system and wavelength provisioning

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621301A (de) * 1961-08-11
FR1338308A (fr) * 1961-08-11 1963-09-27 Roussel Uclaf Stéroïdes aromatiques substitués en position 3 et procédé de préparation
GB984028A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estradiol derivatives and methods for their production
GB984029A (en) * 1963-01-17 1965-02-24 Parke Davis & Co Estrone derivatives and methods for their production
US3519714A (en) * 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
GB9226489D0 (en) * 1992-12-19 1993-02-10 Univ Manchester A joint
KR100984028B1 (ko) * 2008-01-06 2010-10-01 전현철 새콤달콤한 조성물을 난(卵)에 전이하여 구운 새로운 향미의 도포 난(卵) 제조방법
KR102037155B1 (ko) * 2018-11-28 2019-10-28 김훈 다중 레이어를 갖는 프라모델 완성품 보관 및 전시케이스

Also Published As

Publication number Publication date
FR2717690A1 (fr) 1995-09-29
AU698349B2 (en) 1998-10-29
JP3678454B2 (ja) 2005-08-03
JPH07285988A (ja) 1995-10-31
AU1495695A (en) 1995-10-05
RU2176506C2 (ru) 2001-12-10
RU95104235A (ru) 1996-11-27
EP0676202B1 (de) 2000-06-07
DK0676202T3 (da) 2000-10-16
US5739124A (en) 1998-04-14
EP0676202A2 (de) 1995-10-11
CN1111988A (zh) 1995-11-22
KR100367805B1 (ko) 2003-08-02
DE69517356D1 (de) 2000-07-13
FR2717690B1 (fr) 1996-04-26
GR3033882T3 (en) 2000-11-30
ATE193650T1 (de) 2000-06-15
EP0676202A3 (de) 1995-12-27
CA2145469A1 (fr) 1995-09-25
US5580864A (en) 1996-12-03
HU9500846D0 (en) 1995-05-29
HUT72085A (en) 1996-03-28
US5554604A (en) 1996-09-10
CN1055391C (zh) 2000-08-16
US5635498A (en) 1997-06-03
US5672595A (en) 1997-09-30
PT676202E (pt) 2000-09-29
ES2147267T3 (es) 2000-09-01
KR950031078A (ko) 1995-12-18

Similar Documents

Publication Publication Date Title
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
DE69517356T2 (de) Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69123000T2 (de) Neue tricyclische Verbindung oder Salze davon, Verfahren zur Herstellung und antimikrobieller Wirkstoff, der sie enthält
ES2063852T3 (es) Supresion de la sintesis y secrecion de la hormona paratiroide con derivados de vitamina d3.
ES2147907T3 (es) Nuevos acidos y esteres 2,2-dimetil-omega-fenoxi-alcanoicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2044405T3 (es) Un procedimiento para preparar una composicion de carboplatino.
ATE121933T1 (de) Hautfärbende zusammensetzung, die indolderivate und dihydroxyazeton enthält.
DE3861926D1 (de) Polyzyklische aromatische verbindungen, verfahren zu deren herstellung, deren verwendung in menschlicher und tierischer medizin und in der kosmetik.
ATE174026T1 (de) Chromen-derivate mit einer trien-kette zur verwendung bei der behandlung der osteoporose und der entzündlichen erkrankungen
DE3869144D1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE124685T1 (de) 4-phenylmethyl-1h-indol-derivate, verfahren und zwischenverbindungen zu deren herstellung, anwendung als arzneimittel und diese enthaltende zusammensetzungen.
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.
ATE17570T1 (de) Neue 1,1,2-triphenyl-but-1-en-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE97403T1 (de) Indol-carboxamid-derivate und ihre salze, verfahren und zwischenprodukte zur herstellung, anwendung als heilmittel und zusammenstellungen, die sie enthalten.
DE58906207D1 (de) Substituierte 2-Aminothiazole.
DE69230274T2 (de) Verfahren zur Herstellung von Zwischenverbindungen für Vitamin-D-Derivate sowie Verbindungen
DE69003323T2 (de) Flüssige zubereitung für intraokulare perfusion.
DE68903077T2 (de) Benzopyrrolidinon-derivate, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
PT77880A (de) Neue 6alpha-methylprednisolon-derivate ihre herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8339 Ceased/non-payment of the annual fee